Kristina B. Lorvik
Nydalen, 0424, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Development of STEAP1 targeting chimeric antigen receptor for adoptive cell therapy against cancer.
Journal: Molecular therapy oncolytics
Published: September 28, 2021
Enhanced Gut-Homing Dynamics and Pronounced Exhaustion of Mucosal and Blood CD4+ T Cells in HIV-Infected Immunological Non-Responders.
Journal: Frontiers in immunology
Published: July 19, 2021
Probiotics to HIV-Infected Immunological Nonresponders: Altered Mucosal Immunity and Microbial Diversity Restricted to Ileum.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: April 23, 2021
Human Immunodeficiency Virus-Infected Immunological Nonresponders Have Colon-Restricted Gut Mucosal Immune Dysfunction.
Journal: The Journal of infectious diseases
Published: September 01, 2020
Activated dendritic cells and monocytes in HIV immunological nonresponders: HIV-induced interferon-inducible protein-10 correlates with low future CD4+ recovery.
Journal: AIDS (London, England)
Published: February 22, 2019
Plasma IP-10 Is Increased in Immunological NonResponders and Associated With Activated Regulatory T Cells and Persisting Low CD4 Counts.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: September 16, 2016
Interleukin-1 is required for cancer eradication mediated by tumor-specific Th1 cells.
Journal: Oncoimmunology
Published: January 29, 2015
How Do CD4(+) T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules?
Journal: Frontiers in immunology
Published: February 17, 2014
Molecular profiling of tumor-specific TH1 cells activated in vivo.
Journal: Oncoimmunology
Published: January 11, 2013
SH2D2A modulates T cell mediated protection to a B cell derived tumor in transgenic mice.
Journal: PloS one
Published: February 15, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026